Fate Therapeutics, Inc. (FATE)
1.24
-0.06
(-4.62%)
USD |
NASDAQ |
Apr 29, 16:00
1.26
+0.02
(+1.61%)
After-Hours: 20:00
Fate Therapeutics Price : 1.24 for April 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 22.20 |
| Alnylam Pharmaceuticals, Inc. | 301.19 |
| Savara, Inc. | 4.85 |
| BioMarin Pharmaceutical, Inc. | 54.21 |
| Imunon, Inc. | 2.68 |
Price Related Metrics
| PS Ratio | 22.16 |
| Price to Book Value | 0.6958 |
| Earnings Yield | -92.56% |
| Market Cap | 144.17M |